Fibrates: Modes of Action
Author:
Catapano Alberico L.
Publisher
Springer Netherlands
Reference72 articles.
1. Sirtori CR, Franceschini G. Effect of fibrates on serum lipids and atherosclerosis. Pharmac Ther 1988;37:167–191.
2. Kissebah AH, Alfarsi S, Adams PW, Seed M, Folkard J, Wynn V. Transport kinetics of plasma-free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridemia. Effects of 2,2-dimethyl, 5(2,5-xylyloxy) valeric acid therapy. Atherosclerosis 1976;24:199–218.
3. Wong SH, Fisher EA, Marsh JB. Effects of eicosapentaenoic and docosahexaenoic acids on apoprotein B mRNA and secretion of very low density lipoprotein in HepG2 cells. Arteriosclerosis 1989;9:836–841.
4. Nestel PJ, Connor WE, Reardon MF, Connor S, Wong S, Boston R. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest 1984;74:82–89.
5. Kissebah AH, Adams PW, Harrigan P, Wynn V. The mechanism of action of clofibrate and tetranicotinoylfructose (bradilan) on the kinetics of plasma free fatty acid and triglyceride transport in type IV and type V hypertriglyceridaemia. Europ J Clin Invest 1974;4:163–174.